Annals ofHIV - Aids

Volume: 6 - Number: 49 - January 15, 2007

Outstanding

HIV and achalasia.

Increased risk of infant HIV infection with early mixed feeding.

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.

Use of bilirubin as a marker of adherence to atazanavir-based antiretroviral therapy.

Clinical science

Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.

Correspondence

Authors' response to 'HIV and infant feeding: a complex issue in resource-limited settings' by Becquet and Leroy, to the letter to the editors by Coutsoudis et al., and to 'Increased risk of infant HIV infection with early mixed feeding' by Piwoz and Hump

Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance.

Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma.

HIV and achalasia.

HIV and infant feeding: a complex issue in resource-limited settings

Increased risk of infant HIV infection with early mixed feeding.

Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruption.

More to positive prevention than sexually transmitted infection screening

Mycobacterium africanum: a new opportunistic pathogen in HIV infection?.

Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.

Reply to 'Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in Uganda' by Magoni et al.

Response to comments of Paul et al

Response to 'Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients' by Marine-Barjoan et al.

Epidemiology & social

High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.

Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo.

Is HIV-1 evolving to a less virulent (pathogenic) virus?.

Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women.

Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia.

Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?.

The incidence and prevalence of orphanhood associated with parental HIV infection: a population-based study in Rakai, Uganda.

Research letters

Evaluation of the anti-HIV activity of statins.

Response to hepatitis A vaccine in HIV patients in the HAART era.

Susceptibility of Chinese rhesus monkeys to SIV infection

Use of bilirubin as a marker of adherence to atazanavir-based antiretroviral therapy.